Avicanna Financial Statements From 2010 to 2025
| AVCNF Stock | USD 0.25 0.01 4.17% |
Check Avicanna financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avicanna's main balance sheet or income statement drivers, such as , as well as many indicators such as . Avicanna financial statements analysis is a perfect complement when working with Avicanna Valuation or Volatility modules.
Avicanna |
Avicanna OTC Stock Shares Outstanding Analysis
Avicanna's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Avicanna Shares Outstanding | 74.52 M |
Most of Avicanna's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avicanna is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Avicanna has 74.52 M of shares currently outstending. This is 58.72% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 86.97% higher than that of the company.
Avicanna Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avicanna's current stock value. Our valuation model uses many indicators to compare Avicanna value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avicanna competition to find correlations between indicators driving Avicanna's intrinsic value. More Info.Avicanna is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avicanna's earnings, one of the primary drivers of an investment's value.About Avicanna Financial Statements
Avicanna stakeholders use historical fundamental indicators, such as Avicanna's revenue or net income, to determine how well the company is positioned to perform in the future. Although Avicanna investors may analyze each financial statement separately, they are all interrelated. For example, changes in Avicanna's assets and liabilities are reflected in the revenues and expenses on Avicanna's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Avicanna. Please read more on our technical analysis and fundamental analysis pages.
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada. Avicanna operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 124 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Avicanna OTC Stock
Avicanna financial ratios help investors to determine whether Avicanna OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avicanna with respect to the benefits of owning Avicanna security.